These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31333417)

  • 1.
    Bogetofte H; Jensen P; Ryding M; Schmidt SI; Okarmus J; Ritter L; Worm CS; Hohnholt MC; Azevedo C; Roybon L; Bak LK; Waagepetersen H; Ryan BJ; Wade-Martins R; Larsen MR; Meyer M
    Front Cell Neurosci; 2019; 13():297. PubMed ID: 31333417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism.
    Okarmus J; Havelund JF; Ryding M; Schmidt SI; Bogetofte H; Heon-Roberts R; Wade-Martins R; Cowley SA; Ryan BJ; Færgeman NJ; Hyttel P; Meyer M
    Stem Cell Reports; 2021 Jun; 16(6):1510-1526. PubMed ID: 34048689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation.
    Bogetofte H; Jensen P; Okarmus J; Schmidt SI; Agger M; Ryding M; Nørregaard P; Fenger C; Zeng X; Graakjær J; Ryan BJ; Wade-Martins R; Larsen MR; Meyer M
    Neurobiol Dis; 2019 Dec; 132():104581. PubMed ID: 31445161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation.
    Okarmus J; Bogetofte H; Schmidt SI; Ryding M; García-López S; Ryan BJ; Martínez-Serrano A; Hyttel P; Meyer M
    Sci Rep; 2020 Jun; 10(1):10278. PubMed ID: 32581291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines.
    Shaltouki A; Sivapatham R; Pei Y; Gerencser AA; Momčilović O; Rao MS; Zeng X
    Stem Cell Reports; 2015 May; 4(5):847-59. PubMed ID: 25843045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations.
    Gautier CA; Erpapazoglou Z; Mouton-Liger F; Muriel MP; Cormier F; Bigou S; Duffaure S; Girard M; Foret B; Iannielli A; Broccoli V; Dalle C; Bohl D; Michel PP; Corvol JC; Brice A; Corti O
    Hum Mol Genet; 2016 Jul; 25(14):2972-2984. PubMed ID: 27206984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Impact of
    Zilocchi M; Colugnat I; Lualdi M; Meduri M; Marini F; Corasolla Carregari V; Moutaoufik MT; Phanse S; Pieroni L; Babu M; Garavaglia B; Fasano M; Alberio T
    Front Cell Dev Biol; 2020; 8():423. PubMed ID: 32596240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.
    Zanon A; Kalvakuri S; Rakovic A; Foco L; Guida M; Schwienbacher C; Serafin A; Rudolph F; Trilck M; Grünewald A; Stanslowsky N; Wegner F; Giorgio V; Lavdas AA; Bodmer R; Pramstaller PP; Klein C; Hicks AA; Pichler I; Seibler P
    Hum Mol Genet; 2017 Jul; 26(13):2412-2425. PubMed ID: 28379402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of Parkin in skeletal muscle contractile and mitochondrial function.
    Gouspillou G; Godin R; Piquereau J; Picard M; Mofarrahi M; Mathew J; Purves-Smith FM; Sgarioto N; Hepple RT; Burelle Y; Hussain SNA
    J Physiol; 2018 Jul; 596(13):2565-2579. PubMed ID: 29682760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
    Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
    Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a PARK2 homozygous knockout induced pluripotent stem cell line (GIBHi002-A-1) with two common isoforms abolished.
    Zhang M; Ibañez DP; Fan W; Liu H; Zhong X; Wang X; Li Y; Md Abdul M; Li W; Li Y; Ward C; Chen S; Wang D; Qin B; Esteban MA; Zhao P; Luo Z
    Stem Cell Res; 2019 Dec; 41():101602. PubMed ID: 31698191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy.
    Van Laar VS; Roy N; Liu A; Rajprohat S; Arnold B; Dukes AA; Holbein CD; Berman SB
    Neurobiol Dis; 2015 Feb; 74():180-93. PubMed ID: 25478815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.
    Chung SY; Kishinevsky S; Mazzulli JR; Graziotto J; Mrejeru A; Mosharov EV; Puspita L; Valiulahi P; Sulzer D; Milner TA; Taldone T; Krainc D; Studer L; Shim JW
    Stem Cell Reports; 2016 Oct; 7(4):664-677. PubMed ID: 27641647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitylome profiling of Parkin-null brain reveals dysregulation of calcium homeostasis factors ATP1A2, Hippocalcin and GNA11, reflected by altered firing of noradrenergic neurons.
    Key J; Mueller AK; Gispert S; Matschke L; Wittig I; Corti O; Münch C; Decher N; Auburger G
    Neurobiol Dis; 2019 Jul; 127():114-130. PubMed ID: 30763678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.
    Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O
    Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue- and cell-specific mitochondrial defect in Parkin-deficient mice.
    Damiano M; Gautier CA; Bulteau AL; Ferrando-Miguel R; Gouarne C; Paoli MG; Pruss R; Auchère F; L'Hermitte-Stead C; Bouillaud F; Brice A; Corti O; Lombès A
    PLoS One; 2014; 9(6):e99898. PubMed ID: 24959870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin Knockout Inhibits Neuronal Development via Regulation of Proteasomal Degradation of p21.
    Park MH; Lee HJ; Lee HL; Son DJ; Ju JH; Hyun BK; Jung SH; Song JK; Lee DH; Hwang CJ; Han SB; Kim S; Hong JT
    Theranostics; 2017; 7(7):2033-2045. PubMed ID: 28656059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
    Pinto M; Nissanka N; Moraes CT
    J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
    [No Abstract]   [Full Text] [Related]  

  • 20. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.
    Pickrell AM; Huang CH; Kennedy SR; Ordureau A; Sideris DP; Hoekstra JG; Harper JW; Youle RJ
    Neuron; 2015 Jul; 87(2):371-81. PubMed ID: 26182419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.